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eIF4E, the major cap-binding protein, has long been
considered limiting for translating the mammalian
genome. However, the eIF4E dose requirement at an
organismal level remains unexplored. By generating
an Eif4e haploinsufficient mouse, we found that a
50% reduction in eIF4E expression, while compatible
with normal development and global protein syn-
thesis, significantly impeded cellular transformation.
Genome-wide translational profiling uncovered a
translational program inducedby oncogenic transfor-
mation and revealed a critical role for the dose of
eIF4E, specifically in translating a network of mRNAs
enriched for a unique 50 UTR signature. In particular,
we demonstrate that the dose of eIF4E is essential
for translating mRNAs that regulate reactive oxygen
species, fueling transformation and cancer cell sur-
vival in vivo. Our findings indicate eIF4E ismaintained
at levels in excess for normal development that are
hijacked by cancer cells to drive a translational pro-
gram supporting tumorigenesis.
INTRODUCTION
For decades, the major cap binding protein eukaryotic initiation
factor 4E (eIF4E) has been recognized as the quantitatively
limiting initiation factor for mRNA translation (Duncan et al.,
1987; Hiremath et al., 1985). eIF4E is a critical component of
the eIF4F tertiary translation initiation complex, which recog-
nizes the 50 7-methyl guanosine cap of mRNAs and drives their
translation. In addition to eIF4E, the eIF4F complex is comprised
of the DEAD-box helicase eIF4A and eIF4G, a large protein scaf-
fold that recruits the 40S ribosome subunit to mature mRNAs
(Gingras et al., 1999). As the limiting component of the eIF4F
complex, eIF4E expression levels are believed to be critical de-
terminants in translation of eukaryotic mRNAs (De Benedetti
et al., 1991). In particular, the translation of mRNAs harboringstructured 50 UTRs is thought to be exquisitely sensitive to
eIF4E levels due to eIF4E’s ability to both recruit the eIF4A
helicase to the 50cap and stimulate its activity in a cap-indepen-
dent manner (Feoktistova et al., 2013). Collectively, even small
changes in eIF4E levels are believed to broadly impact mRNA
translation and thus cellular and organismal function (Figure 1A).
However, the normal physiological role and threshold for the
dose of eIF4E in organismal development in vivo is essentially
unknown. Moreover, the specific eIF4E dose requirements for
both global and specific translation of mRNAs genome-wide
remain poorly defined.
In this study, we generate a mouse model for Eif4e haploinsuf-
ficiency as a genetic tool to define Eif4e dose requirements
in vivo. Surprisingly, we find that eIF4E exists in excess for
normal development and global protein synthesis and instead
becomes limiting under the specific condition of oncogene-
induced cellular transformation. Employing unbiased genome-
wide profiling to identify the translational landscape of mRNAs
induced by oncogenic transformation, we delineate an ‘‘onco-
genic translation program’’ comprised of hundreds of mRNAs.
Several key nodes in this program, including functional classes
of mRNAs, such as those involved in signaling and control of
reactive oxygen species (ROS), are exquisitely sensitive to the
dose of eIF4E.
One of the defining stress phenotypes that cancer cells
encounter is the buildup of ROS, and cancer cells typically
generate more ROS than do normal cells (Szatrowski and Na-
than, 1991). The ability of cancer cells to distinguish between
ROS as a survival or apoptotic signal is controlled by the dosage
and duration of ROS production, such that modest levels are
required for cancer cell survival, whereas excessive levels pro-
mote cell death (Trachootham et al., 2006; Weinberg et al.,
2010). Here, we show that the capacity to properly translate
mRNAs regulating intracellular ROS levels is critical for tumor
cell survival. Indeed, we demonstrate that reductions in eIF4E
cause a toxic accumulation of ROS rendering, at least in part,
a remarkable resistance to transformation in Eif4e haploinsuffi-
cient mice. These studies thereby reveal a mechanism by which
cancer cells regulate the translation of key stress response
transcripts in a manner that is directly coupled to the dose ofCell 162, 59–71, July 2, 2015 ª2015 Elsevier Inc. 59
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Figure 1. A 50% Reduction in the Dose of
eIF4E Is Compatible with Normal In Vivo
Development and Protein Synthesis
(A) Cartoon demonstrating the current dogma of
eIF4E as quantitatively limiting for protein syn-
thesis. ‘‘7MG’’ denotes the 50 7-methylguanosine
cap. ‘‘eIFs’’ denotes eukaryotic initiation factors
that promote the association of eIF4E with the 40S
ribosomal subunit.
(B) Gross morphology of WT and Eif4e+/ E15.5
embryos.
(C) Representative western blots for eIF4E protein
levels in adult tissues of mice.
(D) Quantitative PCR analysis of Eif4e mRNA
levels in fetal (E11.5) and adult tissues.
(E) Representative western blots for eIF4F com-
plex members and regulators in adult tissues and
primary MEFs.
(F) Global protein synthesis measured by 35S
methionine/cysteine incorporation in MEFs.
(G) Representative polysome profiles of WT
and Eif4e+/MEFs. ‘‘Fr.#’’ denotes the fraction for
sucrose gradient fractionation. Lower molecular
weight (MW) complexes (40S and 60S) are on the
left side of the x axis, and higher MW complexes
(polysomes) are on the right side.
(H) Cap and IRES-dependent translation
measured by luciferase activity in MEFs from
the CMV-HCV-IREST reporter mouse. All values
represent the mean + SEM. Results are repre-
sentative of at least three independent experi-
ments.
See also Figures S1 and S2 and Table S1.eIF4E in the cell. Collectively, these findings highlight that
mammalian cells have evolved a surplus of eIF4E that exists
above the required threshold for normal development and phys-
iology and instead plays a specialized role in regulating mRNA
translation under specific conditions, which has been co-opted
by tumor cells toweather the stress of oncogenic transformation.
RESULTS
In Vivo Requirements for an eIF4E Threshold
In order to address the in vivo requirements for an eIF4E threshold,
we generated an Eif4e knockout mouse (Figures S1A and S1B).
We reasoned that in the context of Eif4e heterozygosity (Eif4e+/),
the impact of a 50% reduction in the level of eIF4E could be as-
sessed genetically at the organismal level to delineate the in vivo
function of eIF4E dose. Surprisingly, Eif4e+/ mice are viable and
indistinguishable from their WT littermates. For example, Eif4e+/
mice are born at normal Mendelian ratios (Table S1) and display
normal body weight (Figure S1C) and survival (data not shown)60 Cell 162, 59–71, July 2, 2015 ª2015 Elsevier Inc.within 1 year of age. In addition, Eif4e+/
embryos and adult mice show normal tis-
sue architecture and development (Fig-
ures 1B, S1D, and S1E) with no obvious
changes in cell size, survival, or prolifera-
tion (Figures S1F, S1G, S2A, and S2B).
Moreover, Eif4e+/ embryos show equal
sensitivity to developmental defects induced by exposure to tera-
togenic agents, such as alcohol (Table S1).
To confirm that eIF4E expression in Eif4e+/ mice is reduced,
we analyzed eIF4E mRNA and protein levels. We observed a
50% reduction in eIF4E expression in virtually all cell and tissue
types examined in vivo (Figures 1C, 1D, S2C, and S2D). Next, we
asked if there might be compensation for eIF4E loss of function
through known translation initiation pathway regulators. How-
ever, we found no evidence of compensation in tissues or cells
of Eif4e+/ mice at the level of expression or phosphorylation
of any other component of the eIF4F initiation complex or of
the inhibitor proteins, eIF4E binding protein 1 and 2 (4EBP1
and 4EBP2), which block the interaction of eIF4Ewith eIF4G (Fig-
ure 1E) (Bah et al., 2015; Haghighat et al., 1995). In addition,
eIF4E activity is directly regulated by phosphorylation at Serine
209 by the Mnk kinases; however, we saw no signs of compen-
sation for reduced eIF4E levels through enhanced phosphoryla-
tion (Figure 1E) (Waskiewicz et al., 1997). As expected, complete
loss of function of eIF4E is not compatible with life and Eif4e/
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Figure 2. eIF4E Is Haploinsufficient for
Oncogenic Transformation
(A) Representative western blots for eIF4F com-
plex members and regulators in WT and Eif4e+/
MEFs before and after overexpression of HRasV12
and Myc.
(B) Quantification of total eIF4E protein levels
relative to b-actin and normalized to primary WT
MEFs.
(C) Quantification of eIF4E phosphorylation rela-
tive to total eIF4E levels in WT MEFs.
(D) Soft agar colony formation as a measure of
oncogenic transformation upon overexpression of
HRasV12 and Myc in WT and Eif4e+/ MEFs with
and without eIF4E rescue (the average WT vector
colony number = 115).
(E) Global protein synthesis measured by 35S
methionine/cysteine incorporation upon trans-
formation in MEFs.
(F) Relative cap and IRES luciferase activity in
transformed MEFs derived from the CMV-HCV-
IREST reporter mouse. Asterisks indicate a sta-
tistically significant change (*p < 0.05; **p < 0.01).
All values represent the mean + SD. Results are
representative of at least three independent
experiments.
See also Figure S2.embryos died before E6.5 (data not shown). Together, these
findings unexpectedly demonstrate that a 50% reduction in
eIF4E is fully compatible with normal organismal development
and physiology in vivo.
Next, we sought to determine the impact of a 50% reduction in
the dose of eIF4E on protein synthesis control in vivo. Remark-
ably, Eif4e+/ mice displayed normal levels of global protein
synthesis as assessed by incorporation of 35S-labeled methio-
nine in primary cells (Figures 1F, S2E, and S2F). Interestingly, re-
ductions in eIF4E in yeast have been shown to cause a dramatic
redistribution of mRNA from actively translating polyribosomes
to monosomes with minimal impacts on global protein synthesis
rates (von der Haar and McCarthy, 2002). However, we found no
evidence for globally altered polysome profiles in Eif4e+/ cells
under exponential growth conditions (Figures 1G and S2G).
Although the majority of translation is thought to be cap depen-
dent and thus to rely on eIF4E activity, reductions in eIF4E could
potentially affect internal ribosomal entry site (IRES)-mediatedCell 162,translation, an alternative form of transla-
tion that is independent of the 50 cap
structure (Macejak and Sarnow, 1991).
To address this question, we employed
a transgenic mouse that stably ex-
presses a bicistronic luciferase reporter
for cap- and IRES-mediated translation
in all tissues (CMV-HCV-IREST) (Bellodi
et al., 2010; Hsieh et al., 2010). By
crossing Eif4e+/ mice with CMV-HCV-
IREST reporter mice and assaying Rluc
and Fluc expression in primary mouse
embryonic fibroblasts (MEFs), we found
that Eif4e+/ mice are not impaired in
either cap- or IRES-mediated translation. These findings demon-
strate that reductions in eIF4E do not induce a switch from cap-
to IRES-dependent translation (Figure 1H).
Eif4e Haploinsufficiency during Cellular Transformation
Next, we asked if eIF4E expression levels are critical during
stress conditions that impinge on protein synthesis, such as dur-
ing the early steps downstream of oncogenic signaling (Barna
et al., 2008). Oncogenic signaling increases expression and
phosphorylation of eIF4E and leads to hyperphosphorylation
and inactivation of the eIF4E inhibitor protein, 4EBP1 (Figures
2A–2C) (Aoki et al., 2001; Rajasekhar et al., 2003; Rosenwald
et al., 1993). Modest overexpression of an eIF4E transgene un-
der the control of the ubiquitous b-actin promoter results in the
formation of multiple cancer types (Ruggero et al., 2004), and
phosphorylation of eIF4E at Ser209 has been shown to be
required for tumorigenesis (Furic et al., 2010). In addition, over-
expression and hyperactivation of eIF4E is a common feature59–71, July 2, 2015 ª2015 Elsevier Inc. 61
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Figure 3. eIF4E Is Required for Expression
of the Oncogenic Translational Program
(A) Representative polysome profiles of trans-
formed and untransformed WT and Eif4e+/ MEFs
separated on a sucrose gradient. Inset highlights
the polysomal fractions (10–13) used for trans-
lational profiling by polysomal microarray.
(B) Changes in total RNA and polysome-associ-
ated RNA in WT MEFs upon oncogenic trans-
formation by HRasV12 and Myc. Green points
indicate genes with a fold change in translation
efficiency (polysomal/total RNA) greater than
1.7-fold; p < 0.05 (see Table S2).
(C) Changes in translation efficiency (TE) induced
by transformation in WT and Eif4e+/ MEFs. Red
points indicate genes whose fold change in TE
during transformation is reduced in Eif4e+/ MEFs
compared to WT MEFs (>1.7-fold decrease in TE;
p < 0.05) (see Table S2).
(D) Network-based cluster analysis of genes and
associated functional classes whose translation
is increased upon transformation in WT MEFs.
Pink nodes represent genes whose translation is
impaired in transformed Eif4e+/ cells.
See also Figure S3 and Table S2.of many human cancers (De Benedetti and Graff, 2004). Yet, it
remains an outstanding question how changes in the levels of
eIF4E expression lead to cellular transformation and whether
this is mediated through control of either global or transcript-
specific mRNA translation.
We first tested the ability of specific oncogenic insults, such as
Ras and Myc, as well as Ras and E1A, to transform primary
Eif4e+/ MEFs under conditions in which eIF4E is genetically
reduced by 50%. Notably, Eif4e+/ MEFs show a consistent
50% reduction in eIF4E expression levels even upon oncogenic
insult (Figures 2A and 2B). Similar to steady state, no compensa-
tion is observed with respect to eIF4E phosphorylation or other
components of the eIF4F initiation complex (Figures 2A–2C).
Additionally, no differences are observed in cell size or expression
of thedrivingoncogenes inEif4e+/ cells compared toWT (Figures
S2H and S2I). Strikingly, Eif4e+/ MEFs are dramatically resistant
to cellular transformation asmeasured by soft agar colony forma-
tion (Figures 2D and S2J). In addition, transformation defects can62 Cell 162, 59–71, July 2, 2015 ª2015 Elsevier Inc.be ascribed specifically to reductions in
the dose of eIF4E as soft agar colony
growth is rescued by restoring eIF4E
expression levels (Figures 2D and S2K).
Thereby, eIF4E dose becomes critical un-
der specific cellular stress conditions,
such as during cellular transformation.
Profiling the Oncogenic Translation
Program
In order to gain insight into the underlying
mechanism by which Eif4e+/ cells are
resistant to oncogenic transformation,
we next asked if the dose of eIF4E is crit-
ical for global protein synthesis duringthis cellular stress. Remarkably, although oncogenic transforma-
tion leads to substantial increases in global protein synthesis
relative to untransformed cells, transformed Eif4e+/ MEFs
showed no defects in global protein synthesis rates asmeasured
by incorporation of 35S-labeled methionine or by assessing Rluc
and FLuc expression in cells isolated from CMV-HCV-IREST
reporter mice (Figures 2E and 2F). In line with this, reductions
in the dose of eIF4E have no impact on the global redistribution
of mRNAs from monosomes to actively translating polysomes
during cellular transformation (Figure S2L).
We therefore asked whether the dose of eIF4E is critical in
regulating the translation of a specific subset of mRNAs integral
to oncogenic transformation. We characterized the impact of
oncogenic signaling on the translational landscape of gene
expression by undertaking an unbiased translational profiling
approach to monitor changes in polyribosomal-associated
mRNA and total transcript levels induced by cellular trans-
formation in WT and Eif4e+/ MEFs (Figure 3A; Table S2). By
comparing the relative differences in the ratio of polysomal
mRNA isolated from high MW sucrose gradient fractions to total
mRNA expression levels (termed translational efficiency), we
identified 722 gene products whose translational efficiency (TE)
was altered by oncogenic transformation with Ras and Myc in
WT MEFs (absolute fold change in TE > 1.7; p < 0.05; Figure 3B;
Table S2). Importantly, we found that the translation of a subset
of 133 gene products is sensitive to the dose of eIF4E, specif-
ically during oncogenic transformation (fold change in TE > 1.7;
p < 0.05; Figures 3C, S3A, and S3B; Table S2).
In order to better understand how the dose of eIF4E impacts
expression of the translational program induced by oncogenic
transformation, we performed network-based cluster analysis
of interactions for the 722 genes that were either translationally
induced (Figures 3D and S3C) or repressed by transformation
(Figure S3D). We found that gene sets translationally regulated
by transformation are enriched in protein-protein interactions
with several functional clusters emerging from this analysis,
including those involved in cell-cycle control, signaling, cell-
to-cell communication, cell adhesion, and protein homeosta-
sis. Moreover, this analysis highlights how specific subsets
of these genes are translated in a manner sensitive to the
dose of eIF4E. It is interesting to note that reductions in the
dose of eIF4E are also associated with the increased transla-
tion of a subset of mRNAs. While the functional relevance of
these changes remains to be determined, they could possibly
reflect mRNAs that are translated in a cap-independent
manner. Thus, employing unbiased genome-wide translational
profiling, we identified a translational program comprised of
722 gene products translationally controlled during cellular
transformation and demonstrated that eIF4E is critical for the
translational activation of a specific subset of this ‘‘oncogenic
translation program.’’
Since our network data analysis suggested that cellular
transformation may promote the translation of distinct classes
of mRNAs, we next performed gene set enrichment analysis
(GSEA) to identify functional classes of genes whose translation
is statistically enriched by cellular transformation and to eval-
uate their eIF4E dose requirements. This analysis revealed a
large and diverse group of functional ontologies whose transla-
tion was enhanced by cellular transformation, including classes
of genes known to be translationally regulated downstream of
oncogenic signaling, such as cell cycle, apoptosis, ribosome
biogenesis, and nucleotide biosynthesis (Table S3) (Cunning-
ham et al., 2014; Hsieh et al., 2010, 2012; Stumpf et al.,
2013). In line with our network interactome data, we find that
eIF4E levels are limiting for the expression of a subset of func-
tional gene classes that are translationally induced by transfor-
mation (Table S3). For example, a 50% reduction in eIF4E
significantly impacts the translation of genes involved in the
proteasome, cell signaling, and nucleotide biosynthesis (Fig-
ure S4A; Table S4).
Strikingly, this analysis also revealed unexpected coordinate
translational upregulation of genes involved in both the produc-
tion of reactive oxygen species (ROS) and the regulation of ROS
levels during cellular transformation. Both oncogenic signaling
and deregulated mitochondrial respiration of cancer cells can
contribute to ROS generation and oncogenic stress (Irani et al.,1997; Sattler et al., 2000; Vafa et al., 2002; Wallace, 2012).
Importantly, the ability of cancer cells to modulate the dosage
and duration of ROS production is vital for their growth and sur-
vival. Mitochondrial oxidative phosphorylation, the main source
of cellular ROS (Wallace, 2012), is one of the functional classes
most translationally enriched by transformation (Figures 4A and
S4B; Table S5). In addition, we found that transformation
enhanced the translation of genes involved in detoxifying and
regulating ROS levels, including glutathione metabolism genes
(Figures S4B and S4C; Table S5). Remarkably, the dose of
eIF4E appears to be critical during cellular transformation for
select translation of mRNAs that control intracellular ROS levels,
but not for mRNAs associated with oxidative phosphorylation
(Table S3).
In order to better understand the eIF4E requirements in
translational control of this distinct class of genes, we next
expanded our functional analysis to more broadly examine
genes involved in the regulation and response to ROS, and
we identified 99 genes translationally induced upon oncogenic
transformation (Figures 4B and S4D; Table S6). Strikingly, we
observed that a large fraction, 26, of these genes are sensitive
to the dose of eIF4E (Figures 4C and S4E; Table S6), including
the ferritin heavy chain (Fth1), the catalytic subunit of gluta-
mate-cysteine ligase (Gclc), and lamin B1 (Lmnb1) (Figures
4D–4F) (Malhas et al., 2009; Pham et al., 2004; Shi et al.,
2000). Importantly, we found that the translation of
genes involved in the regulation and response to ROS was
significantly reduced in Eif4e+/ cells only upon cellular trans-
formation (Figures S4F and S4G). Moreover, qPCR analysis of
polysomal mRNA distribution confirmed that this gene class
was indeed translationally enhanced by transformation in an
eIF4E-dependent manner, as visualized by a diminished shift
of mRNAs into actively translating high MW polysomes in
Eif4e+/ cells upon transformation (Figures S5 and S6). Thus,
this analysis identified groups of functional gene classes whose
translation is induced by transformation in an eIF4E-dependent
manner, including a class of mRNAs involved in the response to
oxidative stress.
A 50 UTR Signature of eIF4E-Dependent mRNAs
It has been previously proposed that long 50 UTRs and com-
plex secondary structures embedded within them, revealed
by high GC content and low free energies, render certain tran-
scripts sensitive to eIF4E activity (Pickering and Willis, 2005).
Importantly, 50 UTR luciferase reporter assays demonstrate
that the 50 UTR of eIF4E target mRNAs, such as Fth1,
Lmnb1, and Edn1, is sufficient to confer translational sensi-
tivity to eIF4E expression levels (Figures 5A and 5B). Surpris-
ingly, however, we see no major differences in 50 UTR length,
GC content, or free energy in eIF4E translational targets
compared to the whole genome (Figure 5C). This suggests
that additional features of specific 50 UTRs may sensitize
them to changes in eIF4E expression levels. In order to identify
potential cis-acting regulatory elements that may confer sensi-
tivity to the dose of eIF4E during oncogenic transformation,
we performed an unbiased Multiple Em for Motif Elicitation
(MEME) search for sequence-specific motifs present in the 50
UTRs of eIF4E-sensitive mRNAs. This analysis identified aCell 162, 59–71, July 2, 2015 ª2015 Elsevier Inc. 63
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Figure 4. eIF4E Is Critical for the Translation
of Distinct Functional Classes of mRNAs
Induced by Oncogenic Transformation
(A–C) GSEA demonstrating (A) enrichment for
genes involved in oxidative phosphorylation (see
Table S5) during cellular transformation (KEGG;
FDR < 0.01), (B) enrichment for a broad class of
genes involved in the regulation and response to
oxidative stress (see Table S6) during cellular
transformation (FDR < 0.01), and (C) Eif4e+/
MEFs are defective in a subset of translationally
regulated genes involved in the regulation and
response to oxidative stress during cellular trans-
formation (see Table S6) (FDR < 0.01). Each
square represents the relative translational effi-
ciency (TE) for a given gene from one individual
biological replicate (n = 3 per group) with red
indicating relatively increased TE and blue indi-
cating decreased TE. The top 15 genes with the
highest enrichment scores are shown for (A) and
(B), and all enriched genes are shown for (C).
(D) Western blot validation of eIF4E ROS target
genes.
(E) Quantification of eIF4E target protein expres-
sion levels. Values represent mean + SEM.
(F) qPCR analysis of eIF4E target mRNA levels.
Values represent mean + SD. Asterisks indicate a
statistically significant change from WT samples
(*p < 0.05; **p < 0.01). Results are representative
of experiments from at least three sets of inde-
pendently isolated primary and transformed WT
and Eif4e+/ cells.
See also Figures S4, S5, and S6 and Tables S3,
S4, S5, and S6.cytosine-rich 15-nucleotide motif that we have termed the
cytosine-enriched regulator of translation (CERT) domain (Fig-
ure 5D; Table S7).
The CERT domain is present in nearly 70% of eIF4E target
mRNAs and is preferentially enriched (81%; p < 0.05) in the sub-
set of eIF4E targets increased by oncogenic transformation,
including oxidative stress response genes like Fth1 (Figure 5D;
Table S7). Notably, this motif is located, on average, 143 nt
downstream of the 50 cap and 146 nt upstream of the AUG start
codon and can be present at multiple copies within the 50 UTR of
target genes. Next, we directly ascertained the possible func-
tional significance of the CERT domain within the context of
eIF4E-sensitized mRNAs identified in this study. Mutations of in-
dividual motifs in the 50 UTR of the eIF4E targets Fth1 and Edn1
are sufficient to restore translational differences conferred by
eIF4E levels, and thus the CERT domain has the potential to
explain, at least in part, target mRNAs that are sensitized to
eIF4E expression levels (Figure 5E). Notably, not all eIF4E targets
contain a CERT motif; thus, it is likely that other context-depen-
dent features of the 50 UTR can confer functionality toward64 Cell 162, 59–71, July 2, 2015 ª2015 Elsevier Inc.eIF4E-selective translation and poten-
tially work in concert with the CERT.
Collectively, these data demonstrate
remarkable translational reprogramming
of genes involved in control of ROS
upon oncogenic transformation that aresensitized to the dose of eIF4E and marked by the presence of
the 50 UTR cis-acting motif.
eIF4E-Dependent Control of ROS during Oncogenic
Transformation and In Vivo Tumorigenesis
Given the unexpected functional role for eIF4E in the expression
of genes involved in the control of reactive oxygen species
during oncogenic transformation, we next examined the ability
of Eif4e+/ cells to regulate and respond to ROS. The ability to
recognize and detoxify ROS is critical for the process of onco-
genic transformation (DeNicola et al., 2011). In particular, the
accumulation of ROS is associated with the high proliferative ca-
pacity and altered mitochondrial respiration of cancer cells and
needs to be detoxified in order to maintain tumor growth (Raj
et al., 2011; Trachootham et al., 2006). In line with decreased
translation of ROS target genes, fluorescent staining with CM-
H2DCFDA reveals that Eif4e+/ cells display elevated levels of
intracellular ROS downstream of oncogenic transformation by
Ras and Myc (Figure 6A). Importantly, we find that transformed
Eif4e+/ cells are significantly more sensitive to both the addition
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(A) Diagram of the 50 UTR luciferase reporter
assay.
(B) Requirements for eIF4E in 50 UTR-mediated
translation of target mRNAs (Fth1, Lmnb1, Gclc,
Edn1, and Pdgfrb) and control mRNAs (Gapdh and
B2M) by 50 UTR luciferase reporter assay in
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tor lacking a 50 UTR. Results are normalized to 50
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(C) Comparison of canonical 50 UTR features be-
tween all mouse genes and the subset whose
translation efficiency is reduced in Eif4e+/ during
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(D) Consensus sequence and enrichment value
(E-value) of the cytosine-enriched regulator of
translation (CERT) motif identified by MEME anal-
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of eIF4E target mRNAs containing a CERT.
(E) Effect of C to G transversion mutations of the
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erase reporter activity in transformed WT and
Eif4e+/ MEFs. Results are normalized to non-
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WT cells. Asterisks indicate a statistically signifi-
cant change (*p < 0.05; **p < 0.01). ns, not signif-
icant. All values represent themean + SEM, except
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See also Table S7.of exogenous ROS and treatment with a redox-cycling agent,
DMNQ, which induces superoxide formation (Figures 6B and
S7A). Indeed, we find that transformed Eif4e+/ cells undergo
programmed cell death under anchorage-independent growth
conditions known to induce the accumulation of ROS (Schafer
et al., 2009), suggesting that eIF4E is required to maintain
accurate levels of ROS compatible with cancer cell survival
(Figure 6C).
To extend these findings to specific genes that control ROS
levels, we examined the roles of Fth1 and Gclc during the pro-
cess of oncogenic transformation. Fth1 encodes an iron storage
protein that possesses intrinsic ferroxidase activity, allowing it to
neutralize toxic reactive oxygen species (Pham et al., 2004).Gclc
encodes the catalytic subunit of glutamate-cysteine ligase, the
rate-limiting enzyme for the synthesis of glutathione used by
glutathione peroxidase to neutralize ROS (Shi et al., 2000).
Importantly, translation of Fth1 and Gclc is significantly
enhanced by oncogenic signaling and highly sensitized to
eIF4E expression levels (Figures 4D and 4E). Strikingly, we find
that knockdown of either Fth1 orGclc is sufficient to inhibit onco-
genic transformation, mirroring the resistance to cellular trans-
formation and sensitivity to ROS observed in Eif4e+/ cells
(Figures 6D–6G and S7B–S7H). Therefore, we asked if the
inability to regulate ROS underlies the transformation defectCell 162,observed in Eif4e+/ cells. Remarkably,
we demonstrate that addition of the anti-
oxidants N-acetyl cysteine (NAC) or Tro-lox, a water-soluble vitamin E analog, is able to significantly
restore the tumorigenic potential of Eif4e+/ cells (Figures 6H,
S7I, and S7J).
Next, we tested eIF4E dose requirements in the setting of
in vivo tumorigenesis driven by endogenous expression of onco-
genic KRas. Importantly, the ability to properly respond to and
control ROS is critical for lung cancer driven by endogenous
expression of oncogenic KRas (DeNicola et al., 2011; Sayin
et al., 2014). Thus, we asked what effect genetically reducing
the dose of eIF4E by 50% would have in the KRasLA2 model of
lung cancer (Figure 7A) (Johnson et al., 2001). We found that
limiting eIF4E levels has a dramatic effect on KRas-driven tumor
initiation as revealed by a significant reduction in tumor number
by 12 weeks of age in Eif4e+/ mice (Figure 7B). Strikingly, this
manifests in a more than 2-fold reduction in tumor burden in
Eif4e+/ mice at 1 year of age (Figures 7C and 7D). Importantly,
we found that reductions in tumor burden and number are
associated with significant increases in oxidative stress, as
measured by the protein oxidation marker dityrosine (Figure 7E).
Moreover, we demonstrated that expression of eIF4E-depen-
dent ROS target genes, such as Fth1 and Gclc, is significantly
reduced in tumors of Eif4e+/ mice (Figures 7F and S7K), further
revealing that eIF4E is critically required for the control of ROS
downstream of cellular transformation in vivo. Next, we asked59–71, July 2, 2015 ª2015 Elsevier Inc. 65
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Figure 6. eIF4E-Dependent Control of Reactive Oxygen Species Is Critical for Cellular Transformation
(A) CM-H2DCFDA mean fluorescence intensity (MFI) quantification by flow cytometry as a relative measure of intracellular ROS levels in transformed WT and
Eif4e+/ MEFs with and without eIF4E rescue.
(B) Annexin V staining as a measure of apoptosis in response to exogenous ROS (2 mM H2O2) in untransformed and transformed MEFs.
(C) Apoptosis under adherent and non-adherent growth conditions in transformed WT and Eif4e+/ MEFs expressing either a non-targeting (n.t.) shRNA or an
Fth1-targeting shRNA.
(D) Soft agar colony formation upon shRNA-mediated knockdown (KD) of three independent Fth1 shRNAs (average WT n.t. shRNA colony number = 115).
(E) Quantification of soft agar colony formation in (D).
(F) Quantification of soft agar colony formation upon shRNA-mediated KD of Gclc (the average WT n.t. shRNA colony number = 97).
(G) Annexin V staining in response to the addition of exogenous ROS (2 mM H2O2) in transformed WT and Eif4e
+/ n.t. shRNA MEFs compared to Fth1 or Gclc
shRNA-mediated KD.
(legend continued on next page)
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if reductions in the dose of eIF4E could confer KRas-driven lung
cancers with enhanced sensitivity to pharmacological induction
of ROS in vivo. We treated KRasLA2mice with the small molecule
piperlongumine (Raj et al., 2011), which selectively increases
levels of ROS, and we monitored the response of WT and
Eif4e+/ tumors by micro X-ray computed tomography. We
found that Eif4e haploinsufficiency renders KRasLA2 tumors
remarkably susceptible to ROS induction compared to WT tu-
mors, leading to significant reductions in tumor volumes upon
treatment that are independent from tumor size (Figures 7G,
7H, and S7L).
To extend our observations to human disease, we asked if
reducing the dose of eIF4E could inhibit the oncogenic potential
of human KRas-driven lung cancer cells through ROS control.
We found that short hairpin RNA (shRNA)-mediated knockdown
of EIF4E in H460 and A549 non-small-cell lung cancer (NSCLC)
cells causes a potent block in their oncogenic potential as
measured by soft agar colony formation (Figures 7I, S7M, and
S7N). Furthermore, we demonstrate that this block in tumorige-
nicity is not only associated with a marked decrease in the
expression of eIF4E-dependent ROS target genes but can also
be rescued, at least in part, by the addition of the antioxidant
NAC (Figures 7I, S7M, and S7N). Together, these data reveal
that the dose of Eif4e becomes critical during tumorigenesis
and delineates an eIF4E-dependent translational program un-
derlying regulation and response to ROS during cellular
transformation.
DISCUSSION
Collectively, our data unexpectedly uncover that eIF4E expres-
sion levels can be maintained at half of the normal genetic
dosage without apparent consequences to normal organismal
development and global mRNA translation. This finding is
consistent with previous cell-based observations showing that
depletion of eIF4E by 80%–90% in rabbit reticulocyte extracts
has only a moderate effect on protein synthesis (Rau et al.,
1996). Interestingly, shRNA-mediated knockdown of eIF4E by
greater than 90% in the HeLa cancer cell line was also shown
to have minimal impacts on global protein synthesis rates; how-
ever, this study demonstrated that sustained protein synthesis
rates could be explained by compensation for reductions in
eIF4E through selective degradation of phospho-4EBP1 (Yana-
giya et al., 2012). It is unclear if this compensation may be a
feature specific to cancer cell lines addicted to high global pro-
tein synthesis rates. Importantly, we find no evidence for similar
alterations in levels or phosphorylation of 4EBPs in primary
Eif4e+/ cells and mice. However, we cannot formally exclude
the potential for unknown compensatory mechanisms arising
from reductions in eIF4E levels. In this regard, it is interesting
to note that eIF4E hyperactivation, both through direct overex-
pression or through deletion of 4EBPs, is also compatible with(H) Restoration of soft agar colony-forming potential in Eif4e+/ MEFs upon additi
colony number = 121). Asterisks indicate a statistically significant change fromWT
are representative of at least three independent experiments.
See also Figure S7.normal organismal development and does not induce any
apparent compensatory feedback mechanisms (Blackshear
et al., 1997; Ruggero et al., 2004). Surprisingly, our data suggest
that mammalian systems have evolved surplus levels of eIF4E
beyond what is required for normal cellular function. Therefore,
it remains an outstanding question what benefit an excess of
eIF4E might convey at the organismal level under normal cellular
conditions. While it is possible that additional translation-inde-
pendent eIF4E functions, such as mRNA transport (von der
Haar et al., 2004), could require higher levels of eIF4E, our data
suggest that the dose of eIF4E may predominately be required
to buffer against specific stress conditions, a function which is
in turn co-opted by cancer cells during the oncogene-induced
stress response that underlies transformation.
Deregulated translation control is a hallmark of human cancers
and is critical for tumorigenesis downstream of multiple onco-
genic signaling pathways (Barna et al., 2008; Hsieh et al.,
2010). However, the full repertoire of mRNAs translationally
altered by oncogenic signaling and the underlying molecular
mechanisms that direct their translational control remain poorly
understood. Employing unbiased genome-wide profiling, we
have uncovered an oncogenic translational program comprised
of hundreds of mRNAs and found that a specific subset of tran-
scripts within this group is exquisitely sensitized to the dose of
eIF4E. Importantly, we have found that translational changes
induced by oncogenic signaling affect many functional gene
classes, such as those involved in cell signaling, apoptosis, ribo-
some biogenesis, the proteasome, nucleotide biosynthesis,
oxidative phosphorylation, and the oxidative stress response,
which may in concert act to promote tumorigenesis. These
data further suggest that translational control of mRNAs
comprising multiple cellular functions are likely to underlie the
remarkable resistance to transformation in Eif4e+/ cells and
mice. In this regard, we have functionally delineated the impact
of translation control of at least one of these functional classes,
a group of mRNAs involved in the regulation and response to
ROS, toward cellular transformation. In particular, we have
shown that key eIF4E-dependent ROS targets, such as Fth1
and Gclc, are critically required for cellular transformation and,
moreover, have demonstrated that antioxidant suppression of
ROS in Eif4e+/ cells rescues to a large extent the cellular trans-
formation capacity of these cells. Future studies will be needed
to further validate the role of other eIF4E-dependent functional
gene classes during tumorigenesis and elucidate specific condi-
tions in which eIF4E-dependent translation of these mRNAs
becomes important.
Oxidative stress is one of the defining stress phenotypes
encountered during tumorigenesis and cancer cells have been
shown to generate more ROS than normal cells (Szatrowski
and Nathan, 1991). In this regard, it has been historically
thought that ROS plays a distinctly pro-tumorigenic role. Recent
studies have also shown that physiological expression ofon of 1 mM of the antioxidant N-acetyl cysteine (NAC) (the average WT control
samples (* = p < 0.05, ** = p < 0.01). All values represent themean + SD. Results
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Figure 7. eIF4E Is Required for Lung Tumorigenesis and Regulation of the Oxidative Stress Response In Vivo
(A) Cartoon outlining experimental mouse crosses used to test the requirements for eIF4E dose during in vivo lung tumorigenesis.
(B) Counts of superficial KRasLA2 lung tumors in WT KRasLA2 mice (n = 11) and Eif4e+/; KRasLA2 mice (n = 10) at 12 weeks of age.
(C) Representative cross-section of lungs from 1-year-old KRasLA2 mice.
(D) Quantification of tumor burden in 1-year-old KRasLA2 mice (WT n = 10 mice; Eif4e+/ n = 5 mice).
(E) Quantification of protein expression for the oxidative stress marker dityrosine in 12-week-old lung tumors (WT n = three tumors, Eif4e+/ n = 3 tumors).
(F) Representative western blots of eIF4E ROS target gene expression in three independent WTKRasLA2 tumors and three independent Eif4e+/; KRasLA2 tumors.
(G) Representative micro X-ray-computed tomography (mCT) cross-sections of established size-matched WT and Eif4e+/ tumors from 8-month-old KRasLA2
mice prior to and after 3 weeks of treatment with the ROS inducer piperlongumine (tumors are outlined in yellow).
(H) Relative tumor volumes of established KRasLA2 tumors followed longitudinally by mCT imaging upon treatment with piperlongumine (WT n = 8 tumors; Eif4e+/
n = 6 tumors).
(legend continued on next page)
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oncogenes may drive down intracellular ROS levels, suggesting
that complex regulation of ROS levels may occur during
different stages of in vivo tumorigenesis, as well as downstream
of progressive genomic aberrations, such as oncogene ampli-
fication. Thereby, our understanding of the key molecular
mechanisms responsible for intricately maintaining ROS levels
compatible with tumor cell survival is incomplete. Here, we
have found that genes regulating ROS are under exquisite
translational regulation during oncogenic transformation and
are sensitized to eIF4E dose, revealing an unexpected post-
transcriptional circuitry regulating ROS levels. For example,
Fth1, an iron-storage protein that protects against the formation
of hydroxyl radicals, and Gclc, the rate-limiting enzyme for the
synthesis of glutathione used to neutralize ROS, are translation-
ally induced by cellular transformation in an eIF4E-dependent
manner. Importantly, we have shown that reductions in eIF4E
dose lead to significant increases in intracellular ROS down-
stream of ectopic oncogene expression, sensitizing tumor cells
to ROS-induced apoptosis and blocking cellular transformation.
In addition, we have demonstrated that eIF4E is required for
proper expression of the ROS response and control of intratu-
moral oxidative stress underlying in vivo lung tumorigenesis
driven by endogenous expression of KRas. Thereby, our data
suggest that the regulation of ROS levels through eIF4E-medi-
ated translational control may provide a molecular rheostat
that fine-tunes the levels of oxidative species that are selectively
required to maintain cancer cell survival.
Precisely how distinct subsets of mRNAs become sensitized
to eIF4E dose during oncogenic transformation remains an
important area of investigation. Classically, long, structured 50
UTRs with high GC content and low free energy have been
thought to be the only features that confer sensitivity to eIF4E
dose. Interestingly, these 50 UTR features were not altered in
the subset of eIF4E-dependent genes translationally activated
by oncogenic transformation. Although we cannot exclude a
possible role for distinct subregions of secondary structures
within the 50 UTRs of eIF4E sensitive genes, our data suggest
that alternativemodes of translational control may also be impor-
tant. Recently, there has been an emerging appreciation for the
role of shorter, sequence-specific elements embedded within
the 50 UTR in directing mRNA translation (Hsieh et al., 2012;
Thoreen et al., 2012; Wolfe et al., 2014; Xue et al., 2015). Along
these lines, we have found that the majority of eIF4E-dependent
mRNAs induced by transformation are marked by the presence
of a sequence-specific CERTmotif within their 50 UTRs, suggest-
ing that this motif may have broader impacts toward eIF4E-
dependent translation. Indeed, within the context of target
mRNAs, such as Fth1 and Edn1, the CERT motif is required to
confer eIF4E sensitivity. However, it remains an outstanding
question how the CERT domain acts mechanistically to couple
the dose of eIF4E to translational control of specific mRNAs. It
is possible, for example, that this motif serves as a docking(I) Soft agar colony formation potential in the H460 humanNSCLC line is decreased
of the antioxidant NAC (average WT control colony number = 139). Asterisks indic
the mean + SEM, except for (I), which represent mean + SD.
See also Figure S7.site for RNA binding proteins that interact either directly or indi-
rectly with eIF4E, potentially to stabilize eIF4E cap binding or
promote eIF4F activity. Future studieswill be required to address
the biochemical mechanisms by which eIF4E interfaces with the
CERT motif and how other context-dependent features of the 50
UTR influence CERT activity.
Collectively, our data surprisingly show that the long-held
dogma that the dose of eIF4E is critically required for trans-
lating the mammalian genome needs to be revisited. Maintain-
ing the dose of eIF4E at 50% of the normal level does not
appear to be detrimental for normal mammalian development
or, even more strikingly, for global protein synthesis control.
Our findings further point to the possibility that cancer cells
have specifically usurped excess eIF4E levels to promote their
growth and survival. The fact that reducing eIF4E expression is
not detrimental for normal mammalian physiology reveals a
potent therapeutic window for targeting the eIF4E-dependent
oncogenic translational program, which may be greatly
enhanced in combination with drugs that exploit the sensitivity
of cancer cells to ROS.
EXPERIMENTAL PROCEDURES
Complete experimental procedures, including details for protein, RNA,
cellular, metabolic, in vivo tumorigenesis, and statistical analysis, can be found
in the Supplemental Experimental Procedures.
Mice
Eif4e genetic loss-of-function mice were generated using embryonic stem
cells from BayGenomics (line RRO036) and validated for gene-trap insertion
by PCR and Southern blot analysis. Eif4e+/ and CMV-HCV-IREST mice
were maintained on a C57BL/6J background. F1 littermates from crosses of
Eif4e+/mice and KRasLA2mice on an FVB/n background were used for in vivo
tumorigenesis experiments. Mice were maintained under specific pathogen-
free conditions, and all experiments were performed in compliance with guide-
lines approved by the Institutional Animal Care and Use Committee of UCSF.
Polysome Fractionation and Isolation of Polysome-Associated RNA
for Microarray
Primary MEFs, transformed MEFs, and lipopolysaccharide-stimulated B cells
were treated with 100 mg/ml cyclohexamide (Sigma) on ice in PBS for 10 min.
Cells were pelleted and lysed in 10 mM Tris-HCl (pH 8), 140 mM NaCl, 1.5 mM
MgCl2, 0.25% NP-40, 0.1% Triton X-100, 50 mM DTT, 150 mg/ml cyclohexa-
mide, and 640 U/ml Rnasin for 30 min. Lysates were cleared, separated on
a 10%–50% sucrose gradient by ultracentrifugation, and fractionated using
an ISCO gradient fractionation system. For polysome microarrays, RNA was
isolated from high MW polysome fractions (fractions 10–13) of three sets of
independently isolated primary and matched-transformed WT and Eif4e+/
MEFs.
Analysis of Microarray Dataset
Affymetrix Mouse Gene 1.0 ST array data were preprocessed by RMA using
the aroma.affymetrix R package. Polysomal and total RNA datasets were
quantile normalized separately. The difference in log2 intensity between
matched polysomal RNA and total RNA was taken to quantify translational
efficiency (TE).upon shRNA-mediated KD of EIF4E and can be rescued by addition of 0.5mM
ate a statistically significant change (*p < 0.05; **p < 0.01). All values represent
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Gene Set Enrichment Analysis
Gene set enrichment analysis (GSEA) was performed using v.2.0.12 of the
GSEA desktop application. Log2 values of translational efficiency (TE) were
input into GSEA and analyzed for enrichment in Kyoto Encyclopedia of
Genes and Genomes and Gene Ontology Biological Process gene set
collections.
Motif Analysis
Multiple Em for Motif Elicitation (MEME) was performed using v.4.9.1 of the
MEME browser application. The training set used to identify the CERT (Table
S7) was compiled from the longest known 50 UTR for RefSeq-annotated
mRNAs called from the UCSC Genome Browser. Gene sets were evaluated
for the presence of the consensus CERT motif using Find Individual Motif
Occurrences (FIMO).ACCESSION NUMBERS
The accession number for the polysome microarray profiling reported in this
paper is GEO: GSE68238.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and seven tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2015.05.049.
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